Anatomical Therapeutic Chemical (ATC) Classification

[ Brite menu | Download htext | Download json | Help ]
Search

1st Level  2nd Level  3rd Level  4th Level  5th Level  6th Level 

 A ALIMENTARY TRACT AND METABOLISM
 
 B BLOOD AND BLOOD FORMING ORGANS
 
 C CARDIOVASCULAR SYSTEM
 
 D DERMATOLOGICALS
   D01 ANTIFUNGALS FOR DERMATOLOGICAL USE
   D02 EMOLLIENTS AND PROTECTIVES
   D03 PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS
   D04 ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
   D05 ANTIPSORIATICS
   D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE
     D06A ANTIBIOTICS FOR TOPICAL USE
     D06B CHEMOTHERAPEUTICS FOR TOPICAL USE
       D06BA Sulfonamides
       D06BB Antivirals
         D06BB01 Idoxuridine
         D06BB02 Tromantadine [DG:DG00405]
         D06BB03 Aciclovir [DG:DG00406]
         D06BB04 Podophyllotoxin
         D06BB05 Inosine [DG:DG00407]
         D06BB06 Penciclovir [DG:DG00408]
           D05407  Penciclovir (USAN/INN) <US>
           D02124  Penciclovir sodium (USAN)
         D06BB07 Lysozyme [DG:DG00409]
         D06BB08 Ibacitabine
         D06BB09 Edoxudine
         D06BB10 Imiquimod
         D06BB11 Docosanol
         D06BB12 Sinecatechins
         D06BB53 Aciclovir, combinations
       D06BX Other chemotherapeutics
     D06C ANTIBIOTICS AND CHEMOTHERAPEUTICS, COMBINATIONS
   D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS
   D08 ANTISEPTICS AND DISINFECTANTS
   D09 MEDICATED DRESSINGS
   D10 ANTI-ACNE PREPARATIONS
   D11 OTHER DERMATOLOGICAL PREPARATIONS
 
 G GENITO URINARY SYSTEM AND SEX HORMONES
 
 H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
 
 J ANTIINFECTIVES FOR SYSTEMIC USE
   J01 ANTIBACTERIALS FOR SYSTEMIC USE
   J02 ANTIMYCOTICS FOR SYSTEMIC USE
   J04 ANTIMYCOBACTERIALS
   J05 ANTIVIRALS FOR SYSTEMIC USE
     J05A DIRECT ACTING ANTIVIRALS
       J05AA Thiosemicarbazones
       J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors [DG:DG02840]
         J05AB01 Aciclovir [DG:DG00406]
         J05AB02 Idoxuridine
         J05AB03 Vidarabine [DG:DG00645]
         J05AB06 Ganciclovir [DG:DG00646]
         J05AB09 Famciclovir
         J05AB11 Valaciclovir [DG:DG00647]
         J05AB12 Cidofovir [DG:DG00648]
         J05AB13 Penciclovir [DG:DG00408]
           D05407  Penciclovir (USAN/INN) <US>
           D02124  Penciclovir sodium (USAN)
         J05AB14 Valganciclovir [DG:DG00649]
         J05AB15 Brivudine
       J05AC Cyclic amines
       J05AD Phosphonic acid derivatives
       J05AE Protease inhibitors [DG:DG01647]
       J05AF Nucleoside and nucleotide reverse transcriptase inhibitors [DG:DG01890]
       J05AG Non-nucleoside reverse transcriptase inhibitors [DG:DG01889]
       J05AH Neuraminidase inhibitors [DG:DG02842]
       J05AP Antivirals for treatment of HCV infections
       J05AR Antivirals for treatment of HIV infections, combinations
       J05AX Other antivirals
   J06 IMMUNE SERA AND IMMUNOGLOBULINS
   J07 VACCINES
 
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
 
 M MUSCULO-SKELETAL SYSTEM
 
 N NERVOUS SYSTEM
 
 P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
 
 R RESPIRATORY SYSTEM
 
 S SENSORY ORGANS
 
 V VARIOUS

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: August 3, 2020
According to WHO's ATC 2020

» Japanese version